Biotechnology company
Appears in 1 story · Last updated Oct 20, 2026
Acquisition target
Merck KGaA agreed on October 19 to buy Silence Therapeutics for $1.3 billion in cash, paying $20 per American Depositary Share. That is 130% above Silence's closing price on October 16.
Updated Oct 20
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
